These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1972750)

  • 1. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
    Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo and in vitro activity of AHR-13268D, a new antiallergic/antihistaminic agent.
    Nolan JC; Foxwell MH; Whitman LL; Johnson DN; Yanni JM; Greene SV
    Agents Actions; 1990 Nov; 31(3-4):210-8. PubMed ID: 1982201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of AHR-5333, a new potential antiallergy compound, in in vivo models of immediate hypersensitivity.
    Yanni JM; Foxwell MH
    Int Arch Allergy Appl Immunol; 1988; 85(4):428-33. PubMed ID: 2895747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators].
    Ohmori K; Ishii H; Nito M; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):399-409. PubMed ID: 6138301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
    Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
    Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SK&F 93944 (Temelastine), a potent histamine H1-receptor antagonist in pharmacologic and antigen-induced bronchoconstriction.
    Malo PE; Muccitelli R; Tucker SS; Wasserman MA
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):461-8. PubMed ID: 2875234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine.
    Nolan JC; Stephens DJ; Proakis AG; Leonard CA; Johnson DN; Kilpatrick BF; Foxwell MH; Yanni JM
    Agents Actions; 1989 Aug; 28(1-2):53-61. PubMed ID: 2571244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiasthma activity of the novel antihistamine E-4716 in guinea pigs in vivo.
    Cortijo J; Farré AJ; Gutierrez B; Morcillo EJ
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):465-73. PubMed ID: 8900220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
    Murai T; Maejima T; Sanai K; Osada E
    Arzneimittelforschung; 1984; 34(11A):1633-40. PubMed ID: 6152156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
    Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
    Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
    Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological study of mequitazine (LM-209) (I). Antagonistic actions of chemical mediators (author's transl)].
    Fujimura H; Tsurumi K; Yanagihara M; Hiramatsu Y; Tamura Y; Shimizu Y; Hojo M; Yoshida Y
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):279-89. PubMed ID: 6120126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of the new H1-receptor antagonist setastine hydrochloride.
    Porszász J; Varga F; Porszász KG; Szolscányi J; Barthó L; Petöcz L; Kápolnai L
    Arzneimittelforschung; 1990 Dec; 40(12):1340-5. PubMed ID: 1982751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic studies on W10,294A, a new bronchodilator.
    Giles RE; Williams JC; Finkel MP
    J Pharmacol Exp Ther; 1977 Dec; 203(3):701-11. PubMed ID: 21958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.